Search details
1.
RIG-I modulates Src-mediated AKT activation to restrain leukemic stemness.
Mol Cell
; 53(3): 407-19, 2014 Feb 06.
Article
in English
| MEDLINE | ID: mdl-24412064
2.
Leukemic IL-17RB signaling regulates leukemic survival and chemoresistance.
FASEB J
; 33(8): 9565-9576, 2019 08.
Article
in English
| MEDLINE | ID: mdl-31136196
3.
Viral RNA-Unprimed Rig-I Restrains Stat3 Activation in the Modulation of Regulatory T Cell/Th17 Cell Balance.
J Immunol
; 199(1): 119-128, 2017 07 01.
Article
in English
| MEDLINE | ID: mdl-28550197
4.
A CD36-dependent non-canonical lipid metabolism program promotes immune escape and resistance to hypomethylating agent therapy in AML.
Cell Rep Med
; : 101592, 2024 May 29.
Article
in English
| MEDLINE | ID: mdl-38843841
5.
Leukemic progenitor cells enable immunosuppression and post-chemotherapy relapse via IL-36-inflammatory monocyte axis.
Sci Adv
; 7(41): eabg4167, 2021 Oct 08.
Article
in English
| MEDLINE | ID: mdl-34623912
6.
JMJD3 facilitates C/EBPß-centered transcriptional program to exert oncorepressor activity in AML.
Nat Commun
; 9(1): 3369, 2018 08 22.
Article
in English
| MEDLINE | ID: mdl-30135572
7.
Tumor suppressor activity of RIG-I.
Mol Cell Oncol
; 1(4): e968016, 2014.
Article
in English
| MEDLINE | ID: mdl-27308362
Results
1 -
7
de 7
1
Next >
>>